3Bellini V,Simonetti S,Lisi P.Successful treatment of severe pyoderma gangrenosum with pimecrolimus cream 1%.J Eur Acad Dermatol Venereol 2008;22(1):113-115.
4Kim TY,Han DS,Eun CS,et al.Recombinant human epidermal growth factor enhances wound healing of pyoderma gangrenosum in a patient with ulcerative colitis.Inflamm Bowel Dis 2008;14(5):725-727.
5Gupta AK,Adamiak A,Chow M.Tacrolimus:a review of its use for the management of dermatoses.J Eur Acad Dermatol Venereol 2002;16(2):100-114.
6Daniels NH,Callen JP.Mycophenolate mofetil is an effective treatment for peristomal pyoderma gangrenosum.Arch Dermatol 2004;140(12):1427-1429.
7Eaton PA,Callen JP.Mycophenolate mofetil as therapy for pyoderma gangrenosum.Arch Dermatol 2009;145(7):781-785.
8Lee MR,Cooper AJ.Mycophenolate mofetil in pyoderma gangrenosum.J Dermatol Treat 2004;15(5):303-307.
9de Zwaan SE,Iland HJ,Damian DL.Treatment of refractory pyoderma gangrenosum with intravenous immunoglobulin.Australas J Dermatol 2009;50(1):56-59.
9Gholam D;Chebib A;Hauteville D.Combined paclitaxel and cetuximab achieved a major response on the skin metastases of a patient with epidermal growth factor receptor-positive,e- strogen receptor-nega-tive,progesterone receptor-negative and human epidermal growth factor receptor-2-negative (triple-negative) breast cancer[J].Anti-Cancer Drugs,2007,18(7):835-837.
10Mendelson K9Swendeman S,Saftig P et al.Stimulation of platelet-derived growth factor receptor beta (PDGFRbeta) activates ADAM 17 and promotes metalloproteinase-depen- dent cross-talk between the PDGFRbeta and epidermal growth factor receptor (EGFR) signaling pathways.[J].The Journal of biological chemistry,2010,285(32):25024-25032.
